IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — MRNA

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents1.721.911.131.281.621.642.482.052.933.803.443.032.875.055.555.605.44
Accounts Receivable0.020.071.050.040.081.560.160.141.870.231.112.702.693.173.142.023.21
Inventory0.280.150.330.240.130.410.400.300.490.720.732.081.921.940.970.640.49
Total Current Assets5.825.776.606.176.779.679.669.6010.8010.6012.1214.3013.5616.3513.4310.9711.70
Property, Plant & Equipment2.062.092.132.172.212.382.202.061.952.282.022.021.321.340.850.790.37
Goodwill0.050.050.050.050.050.050.050.050.050.050.05------------
Intangible Assets0.110.120.050.050.050.040.040.040.050.050.05------------
Total Non-current Assets*5.155.725.545.845.946.146.027.138.6511.2912.0011.7612.4811.267.505.180.99
Total Assets10.9611.4912.1412.0112.7015.8015.6816.7319.4521.8824.1326.0626.0427.6120.9216.1512.69
Accounts Payable0.170.160.270.180.230.370.280.180.490.310.390.330.180.200.090.080.01
Total Current Liabilities2.532.401.681.571.602.202.362.384.393.123.506.816.819.249.968.848.44
Long-term Debt0.590.59------------------------------
Total Non-current Liabilities*1.671.691.121.041.031.681.611.531.611.811.761.261.251.300.840.610.42
Total Liabilities4.204.082.812.612.643.883.973.916.004.935.268.068.0610.5310.809.458.86
Retained Earnings5.105.888.058.259.0711.1711.1512.4313.3917.0218.4016.8615.8113.625.091.76(1.02)
Total Stockholder Equity6.767.419.339.4010.0711.9311.7112.8213.4616.9518.8617.9917.9917.0810.126.703.84

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.140.390.681.020.140.110.971.860.240.172.811.830.341.865.083.364.756.077.214.97
Cost of Revenue0.090.960.450.210.120.090.740.510.120.100.932.240.730.791.921.101.381.020.950.72
Gross Profit0.05(0.57)0.230.810.020.020.231.350.130.071.88(0.41)(0.39)1.073.172.263.375.056.264.25
Research & Development0.650.650.780.800.700.861.121.141.221.061.411.161.151.131.210.820.710.550.650.52
Selling, General & Admin0.220.170.310.270.230.210.350.280.270.270.470.440.330.310.380.280.210.270.200.17
Total Operating Expenses0.870.821.081.070.931.071.471.421.491.341.881.601.481.441.591.100.920.820.850.69
Operating Income(0.81)(1.39)(0.86)(0.26)(0.91)(1.05)(1.25)(0.07)(1.36)(1.27)0.01(2.01)(1.87)(0.37)1.581.172.454.235.413.56
Pretax Income(0.77)(1.33)(0.80)(0.19)(0.82)(0.96)(1.18)0.02(1.28)(1.16)0.07(1.96)(1.75)(0.30)1.661.222.474.235.413.55
Tax Provision0.020.010.030.010.010.01(0.06)0.010.000.01(0.15)1.67(0.37)(0.38)0.190.170.280.570.540.22
Net Income(0.78)(1.34)(0.83)(0.20)(0.82)(0.97)(1.12)0.01(1.28)(1.17)0.22(3.63)(1.38)0.081.471.042.203.664.873.33
Basic EPS(1.97)(3.40)(2.10)(0.51)(2.13)(2.52)(2.91)0.03(3.33)(3.07)0.62(9.53)(3.62)0.203.952.675.559.0912.068.27
Diluted EPS(1.97)(3.40)(2.10)(0.51)(2.13)(2.52)(2.91)0.03(3.33)(3.07)0.63(9.53)(3.62)0.193.772.535.248.5811.297.70

Cash Flow Statement

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(0.53)(0.63)0.93(0.85)(0.92)(1.04)0.83(1.57)(1.27)(0.99)0.62(1.60)(0.91)(1.23)1.660.250.302.763.313.28
Capital Expenditures0.040.060.040.030.000.120.520.150.180.200.220.140.230.110.090.090.090.130.120.10
Free Cash Flow*(0.56)(0.69)0.89(0.88)(0.92)(1.15)0.30(1.72)(1.46)(1.18)0.40(1.74)(1.15)(1.34)1.570.160.222.633.193.18
Investing Cash Flow0.33(0.08)(0.05)0.700.560.73(0.54)0.721.650.12(0.54)0.791.942.01(1.05)0.95(1.15)(3.92)(1.14)(3.33)
Financing Cash Flow0.010.020.58-0.000.010.00-0.000.010.030.01(0.11)(0.06)(0.67)(0.54)(0.44)(1.04)(1.33)(0.64)(0.87)-0.00

* Derived from reported values